서브비주얼

Keynote Speakers

Day 1(July 3, 2025

Opening

Welcoming remarks

  • Youngmee Jee

    Commissioner,
    Korea Disease Control Prevention Agency(KDCA)

    Education

    • 1997 영국, 런던대 바이러스학 박사
    • 1988 영국, 런던대 의학미생물학 Diploma
    • 1986 서울대학교 의학과 졸업

    Experience

    • 2022 ~ 현재 질병관리청장
    • 2017 ~ 2019 질병관리본부 감염병연구센터장
    • 2014 ~ 2017 질병관리본부 면역병리센터장
    • 2007 ~ 2014 WHO 서태평양지역본부 지역조정관
    • 2005 ~ 2078 국립보건연구원 간염폴리오바이러스팀장
    • 2003 ~ 2005 국립보건연구원 소화기바이러스과장
    • 1997 ~ 2003 국립보건연구원 소화기바이러스과
    • 민간 경력
    • 2021 ~ 2022 국제백신연구소(IVI) 이사
    • 2021 ~ 2021 대한미생물학회 회장
    • 2016 ~ 2019 국제백신연구소(IVI) 이사
    • 2017 ~ 2000 WHO 예방접종전략자문위원회(SAGE) 위원
    • 2017 ~ 2019 대한감염학회 회장
    • 2000 ~ 현재 WHO 코로나19 긴급위원회 위원
    • 2000 ~ 2022 국제교류재단 보건외교 특별대표
    • 2000 ~ 2021 서울대학교 행정대학원 보건의료 분야 객원교수
    • 2000 ~ 2021 국무총리 보건 분야 특별보좌관
  • Congratulatory Remarks

    TBD

    TBD,
    Ministry of Health and Welfare(MOHW)

    Education

    Experience

  • Congratulatory Remarks

    Young-Su Ju

    President,
    National Medical Center(NMC)

    Education

    Experience

  • Congratulatory Remarks

    TBD

    President,
    Samsung’s social contribution business

    Education

    Experience

Overview of KH Donation Initiatives

Keynote Speech

  • Hee-Chang Jang

    Director,
    Korea National Institute of Infectious Diseases, KNIH, KDCA

    Education

    Experience

Session 1. Building Research Infrastructure for Global Clinical Trial Networks on Infectious Diseases and AMR Surveillance

Chair

  • Myung-Don Oh

    Chairman,
    Donation Management Committee

    Education

    Experience

  • Dong-Gun Lee

    Chairperson,
    The Korean Society of Infectious Diseases

    Education

    Experience

Speaker

  • David Paterson

    Professor,
    National University of Singapore

    Topic

    • Clinical trial collaboration networks : ADVANCE-ID and AMR research

    Summary

  • Hong-Bin Kim

    Professor,
    Seoul National University Bundang Hospital

    Topic

    • Clinical trial networks by ID specialty hospital and collaboration for global networks

    Summary

  • Elizabath Seale Higgs

    NIAID, USA

    Topic

    • Clinical trial network during COVID19 pandemic and Beyond : ACTIV and STRIVE

    Summary

  • Robert Schooley

    Co-director,
    UC San Diego IPATH, USA)

    Topic

    • Critical role of Bacteriophages in adressing Global AMR CRISIS

    Summary

  • Dong-Eun Yong

    CEO/Professor,
    MicrobiotiX /Yonsei University

    Topic

    • Application of phages as medical reagents

    Summary

Session 2: Strengthening Medical Research Capacity for Pandemic Response at Infectious Disease Hospitals

Chair

  • Seung-Kwan Lim

    General Director,
    Central Infectious Disease Hospital Establishment Promotion Team

    Education

    Experience

  • Hong-In Roh

    Operational Accounting Chairman,
    Donation Management Committee

    Education

    Experience

Speaker

  • TBD

    TBD

    Topic

    • Development and utilization of the WHO Global Clinical Platform for the next pandemic response

    Summary

  • Myung-Hee Kim

    Director,
    Policy Statistics Support Center

    Topic

    • Predicting Healthcare Demands in Pandemic Scenarios: Insights from Statistical Modelling and Big Data

    Summary

  • Deborah W Gould

    Senior advisor,
    CDC, USA

    Topic

    • Introduction to the National Syndromic Surveillance Program in the United States

    Summary

  • Ki-Tae Kwon

    Professor,
    Kyungpook National University Chilgok Hospital

    Topic

    • Efficient Hospital Bed Assignment and Resource Allocation Strategies for Pandemic Response

    Summary

Closing

Closing Remarks

  • Seung-Kwan Lim

    General Director,
    Central Infectious Disease Hospital Establishment Promotion Team

    Education

    Experience